AnalystsPaul ChoiPaul Choi's Stock Forecasts
AnalystsPaul Choi
Analyst Ranking
Bottom 11%
#4063 out of 4554 analysts
Average Return
-3.81%
Win Rate
40%20 out of 50
Risk vs Reward
Poor
Good
Paul Choi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pandion Therapeutics IncPAND | +218.57% | $18.85 | $60.05 | 2020-08-10 - 2021-03-31 | Strong Buy |
Tesaro IncTSRO | +177.42% | $27.02 | $74.96 | 2018-08-05 - 2019-01-18 | Strong Buy |
Cytokinetics IncCYTK | +102.36% | $33.11 | $67.00 | 2023-11-08 - 2024-04-18 | Strong Buy |
Fibrogen IncFGEN | +96.10% | $14.15 | $0.55 | 2022-11-07 - 2023-11-07 | Strong Sell |
Fibrogen IncFGEN | +92.04% | $22.60 | $1.80 | 2023-02-20 - 2024-02-20 | Strong Sell |
Paul Choi Analyst Color
Get additional color on Paul Choi's coverage of popular stocks
Paul Choi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gossamer Bio IncGOSS | 3 | Strong Buy | $8.00 | +892.56% | Maintains | a month ago |
Arvinas IncARVN | 1 | Strong Buy | $70.00 | +104.14% | Initiates Coverage On | 3 months ago |
Dynavax Technologies CorpDVAX | 1 | Hold | $20.00 | +76.37% | Initiates Coverage On | 3 months ago |
Hutchmed LtdHCM | 5 | Hold | $17.00 | +3.91% | Maintains | 5 months ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $50.00 | -25.37% | Initiates Coverage On | 5 months ago |
Phathom Pharmaceuticals IncPHAT | 4 | Hold | $10.00 | +5.49% | Maintains | 6 months ago |
Ptc Therapeutics IncPTCT | 3 | Strong Sell | $22.00 | -10.90% | Maintains | 7 months ago |
Urogen Pharma LtdURGN | 2 | Hold | $18.00 | +26.23% | Maintains | 9 months ago |
Kiniksa Pharmaceuticals LtdKNSA | 1 | Strong Buy | $32.00 | +89.57% | Maintains | 9 months ago |
Vir Biotechnology IncVIR | 6 | Strong Buy | $28.00 | +251.76% | Maintains | 9 months ago |
Amarin Corp PLCAMRN | 4 | Strong Sell | $1.00 | +14.68% | Maintains | 9 months ago |
Bridgebio Pharma IncBBIO | 3 | Strong Buy | $50.00 | +100.40% | Maintains | 9 months ago |
Foghorn Therapeutics IncFHTX | 2 | Strong Buy | $19.00 | +243.58% | Maintains | 10 months ago |
Fibrogen IncFGEN | 5 | Strong Sell | $2.00 | +70.94% | Maintains | 10 months ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $26.00 | N/A | Maintains | a year ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | a year ago |
Ascendis Pharma AASND | 1 | Strong Buy | $174.00 | N/A | Initiates Coverage On | a year ago |
Ngm Biopharmaceuticals IncNGM | 1 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Ars Pharmaceuticals IncSPRY | 1 | Hold | $3.50 | N/A | Downgrades | 2 years ago |
Allakos IncALLK | 2 | Hold | $60.00 | N/A | Maintains | 2 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Strong Buy | $170.00 | N/A | Maintains | 3 years ago |
Axcella Health IncAXLA | 2 | Hold | $125.00 | N/A | Downgrades | 3 years ago |
Korro Bio IncKRRO | 1 | Hold | $9.00 | N/A | Downgrades | 3 years ago |
Pmv Pharmaceuticals IncPMVP | 2 | Strong Buy | $43.00 | N/A | Upgrades | 3 years ago |
Puma Biotechnology IncPBYI | 4 | Strong Sell | $8.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $132.00 | N/A | Assumes | 3 years ago |
Radius Health IncRDUS1 | 1 | Strong Buy | $33.00 | N/A | Assumes | 3 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $112.00 | N/A | Assumes | 3 years ago |
Esperion Therapeutics IncESPR | 1 | Strong Sell | $24.00 | N/A | Downgrades | 3 years ago |
Myovant Sciences LtdMYOV | 1 | Hold | $30.00 | N/A | Downgrades | 3 years ago |
Pandion Therapeutics IncPAND | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Viela Bio IncVIE | 3 | Hold | $49.00 | N/A | Upgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $103.00 | N/A | Upgrades | 4 years ago |
Neurocrine Biosciences IncNBIX | 1 | Hold | $135.00 | N/A | Downgrades | 4 years ago |
Dianthus Therapeutics IncDNTH | 1 | Strong Buy | $15.00 | N/A | Upgrades | 4 years ago |
Immunomedics IncIMMU | 2 | Hold | $22.00 | N/A | Upgrades | 4 years ago |
Nektar TherapeuticsNKTR | 1 | Hold | $20.00 | N/A | Upgrades | 4 years ago |
Clovis Oncology IncCLVSQ | 3 | Strong Buy | $40.00 | N/A | Maintains | 5 years ago |
Tesaro IncTSRO | 3 | Strong Buy | $56.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.